High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker

Abstract Distinguishing indolent from clinically significant localized prostate cancer is a major clinical challenge and influences clinical decision-making between treatment and active surveillance. The development of novel predictive biomarkers will help with risk stratification, and clinical deci...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Shiqin Liu, Sarah J. Hawley, Christian A. Kunder, En-Chi Hsu, Michelle Shen, Lennart Westphalen, Heidi Auman, Lisa F. Newcomb, Daniel W. Lin, Peter S. Nelson, Ziding Feng, Maria S. Tretiakova, Lawrence D. True, Funda Vakar-Lopez, Peter R. Carroll, Jeffry Simko, Martin E. Gleave, Dean A. Troyer, Jesse K. McKenney, James D. Brooks, Michael A. Liss, Tanya Stoyanova
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2024-01-01
Colecção:	Scientific Reports
Acesso em linha:	https://doi.org/10.1038/s41598-023-50215-z
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!